FDA Approved: HYDROXYZINE PAMOATE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for hydroxyzine pamoate submitted by Sandoz Inc. The action relates to a generic product under ANDA 086183.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Pruritus

Drugs mentioned

• Hydroxyzine pamoate (Hydroxyzine pamoate)

Snippet

SUPPL AP for HYDROXYZINE PAMOATE (HYDROXYZINE PAMOATE)